Inmunoterapia preventiva

Allergologia et Immunopathologia

Volumn 28, Issue 3, 2000, Pages 89-93

  Boquete, M ^a   Carballada, F ^a   Exposito F ^a   Gonzalez, A L ^a  

^a HOSPITAL XERAL CALDE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT;

ADOLESCENT; ADULT; ANIMAL; ASTHMA; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONSENSUS DEVELOPMENT; CONTROLLED CLINICAL TRIAL; DESENSITIZATION; DOUBLE BLIND PROCEDURE; HAY FEVER; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INSECT BITE; MITE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PERENNIAL RHINITIS; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; REVIEW; SEASON; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CONSENSUS DEVELOPMENT CONFERENCES; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INSECT BITES AND STINGS; MITES; MULTICENTER STUDIES; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SEASONS; WORLD HEALTH ORGANIZATION;

EID: 0034185050     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Abramson M, Puy R, Weiner J. Is allergen immunotherapy effective in asthma? A meta-analysis of randomised controlled trials. Am J Respir Crit Care Med 1995;151:969-74.
2. Abramson MJ, Puy RM, Weiner JM. Allergen specific immunotherapy for asthma (Cochrane Review). Oxford: Cochrane Library; 1998.
3. Abramson M, Puy R, Weiner J. Immunotherapy in asthma an updated systematic review. Allergy 1999;54:1022-41.
4. Bousquet J, Lockey RF, Malling HJ. Allergen immunotherapy - therapeutic vaccines for allergic diseases. Allergy 1998;53(Supl44):4-42.
5. Van Bever HP, Vereecke IF, Brids CH, De Clerk LS, Steven WJ. Comparison between the in vitro cytokine production of mononuclear cells of young asthmatics with and without immunotherapy (IT). Clin Exp Allergy 1998;28:943-9.
6. Calvo M, Marlin F, Grob K et al. Ten year follow up in paediatric patients with allergic asthma: evaluation of specific immunotherapy. Clin Immunol 1994;4:126-31.
7. Jacobsen L, Nuchel Petersen B, Wihl JA et al. Immunotherapy with partially purified and standardised tree pollen extracts IV. Results from long term (6 years) follow up. Allergy 1997;52:914-20.
8. Mosbeck HL, Osterballe O. Does the effect of immunotherapy last after termination of treatment? Allergy 1988;43:523-9.
9. Rack S, Lowhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen allergic patients
10. Hedlin G, Graff Lonnevig V, Heiborn H, Lilja G, Norlind K, Pegelow K et al. Immunotherapy cat and dog dander extracts V. Effects of 3 years of treatment J Allergy Clin Immunol 1991;87:955-64.
11. Valovirta E. Capacity of specific immunotherapy in prevention of allergic asthma: The preventive allergic treatment study (PAT). J Investig Allergol Clin Immunol 1997;7:369-70.
12. Des Roches A, Paradis L Menardo JL, Immunotherapy with a standardised Dermatophagoides pteronyssinus extract IV. Specific immunotherapy prevents the onset of new sensitisation in children J Allergy Clin Immunol 1997;99:450-3.
13. Jacobsen L. Preventive allergy treatment as part of allergy disease management. J Allergy Clin Immunol 1997;7:367-8.
14. Cools M, Weyler JJ, Stevens WJ. Long term effects of specific immunotherapy, administered during childhood, in asthmatic patients allergic to either house dust mite or to both house dust mite and grass pollen. Allergy 2000;55:69-73.